Integrating non-drug treatments in early schizophrenia

Summary There is a range of psychological interventions for established schizophrenia. These include family interventions, motivational interventions for substance misuse and for non-adherence to medication, cognitive remediation for neurocognitive deficits and cognitive–behavioural therapy for symptoms. Psychological interventions may explicitly target risk factors for poor outcome, such as substance use, or protective factors, such as adherence to medication, or be directed at specific symptoms or deficits. There is emerging evidence for efficacy of psychological treatments during, following and even prior to the first episode. Important areas for further study are how different treatment modalities can interact productively and patient and carer preferences for treatment. Many trials of psychological treatments have design flaws and this tends to overestimate the treatment effect.

[1]  S. Lewis,et al.  Duration of untreated psychosis and its relationship to clinical outcome , 2005, British Journal of Psychiatry.

[2]  N. Tarrier,et al.  Cognitive–behavioural therapy in first-episode and early schizophrenia , 2004, British Journal of Psychiatry.

[3]  N. Tarrier,et al.  A trial of two cognitive behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients , 1993, Social Psychiatry and Psychiatric Epidemiology.

[4]  S. Lewis,et al.  Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort , 2003, Schizophrenia Research.

[5]  N. Tarrier,et al.  Cognitive–behavioural therapy and motivational intervention for schizophrenia and substance misuse , 2003, British Journal of Psychiatry.

[6]  T. McGlashan,et al.  Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome , 2003, Biological Psychiatry.

[7]  R. Drake,et al.  Insight and neurocognition in schizophrenia , 2003, Schizophrenia Research.

[8]  B. Everitt,et al.  Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia , 2003, Schizophrenia Research.

[9]  J. Norrie,et al.  Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy , 2003, Psychological Medicine.

[10]  P. Buckley,et al.  Treatment of the psychotic patient who is violent. , 2003, The Psychiatric clinics of North America.

[11]  D. Streiner,et al.  Family intervention for schizophrenia. , 2003, The Cochrane database of systematic reviews.

[12]  Stephan Arndt,et al.  Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. , 2003, The American journal of psychiatry.

[13]  J. Rey,et al.  Cannabis and mental health , 2002, BMJ : British Medical Journal.

[14]  Richie Poulton,et al.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study , 2002, BMJ : British Medical Journal.

[15]  Glyn Lewis,et al.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study , 2002, BMJ : British Medical Journal.

[16]  Hok Pan Yuen,et al.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.

[17]  N. Tarrier,et al.  Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: Acute-phase outcomes , 2002, British Journal of Psychiatry.

[18]  T. Robbins,et al.  Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: The West London Study , 2002, British Journal of Psychiatry.

[19]  N. Tarrier,et al.  NEW DEVELOPMENTS IN COGNITIVE-BEHAVIOURAL CASE FORMULATION. EPIDEMIOLOGICAL, SYSTEMIC AND SOCIAL CONTEXT: AN INTEGRATIVE APPROACH , 2002 .

[20]  F. Guillem,et al.  The dimensional symptom structure of schizophrenia and its association with temperament and character , 2002, Schizophrenia Research.

[21]  A. Vergouwen,et al.  Patient adherence with antidepressant treatment. , 2002, The British journal of psychiatry : the journal of mental science.

[22]  S. Lawton-Smith Patient adherence with antidepressant treatment , 2002, British Journal of Psychiatry.

[23]  D. Kingdon,et al.  Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. , 2002, The British journal of psychiatry : the journal of mental science.

[24]  P. McGorry,et al.  Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia , 2002, Schizophrenia Research.

[25]  W. Gaebel,et al.  First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies , 2002, Schizophrenia Research.

[26]  T. Russell,et al.  Further independent evidence for symptom-specific deficits in theory of mind in schizophrenia , 2002 .

[27]  S. Leucht,et al.  The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. , 2004, Schizophrenia bulletin.

[28]  N. Tarrier,et al.  Needs-based cognitive-behavioural family intervention for carers of patients suffering from schizophrenia: 12-month follow-up. , 2001 .

[29]  N. Tarrier,et al.  Needs‐based cognitive‐behavioural family intervention for carers of patients suffering from schizophrenia: 12‐month follow‐up , 2001, Acta psychiatrica Scandinavica.

[30]  C. Barrowclough,et al.  Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. , 2001, The American journal of psychiatry.

[31]  D. Linszen,et al.  Social Functioning and the Course of Early-Onset Schizophrenia , 2001, British Journal of Psychiatry.

[32]  R. Murray,et al.  Comprehensive care of schizophrenia : a textbook of clinical management , 2001 .

[33]  R. Drake,et al.  Causes and consequences of duration of untreated psychosis in schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.

[34]  S. Lawrie,et al.  Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study , 2000, Psychological Medicine.

[35]  I. Gottesman,et al.  Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. , 2000, The American journal of psychiatry.

[36]  J. Os,et al.  Medication adherence in psychosis: predictors and impact on outcome.A 2‐year follow‐up of first‐admitted subjects , 2000, Acta psychiatrica Scandinavica.

[37]  Philip D. Harvey,et al.  Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. , 2000, The American journal of psychiatry.

[38]  T. Sharma,et al.  Neuropsychological functioning in first-episode psychosis — evidence of specific deficits , 2000, Schizophrenia Research.

[39]  J. Lieberman,et al.  Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.

[40]  C. Adams,et al.  Influence of methodology on outcomes of randomised clozapine trials. , 2000, Pharmacopsychiatry.

[41]  T. Sensky,et al.  A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. , 2000, Archives of general psychiatry.

[42]  T. Sharma,et al.  Neuropsychological functioning in first-episode psychosis — evidence for specific deficits , 2000, Schizophrenia Research.

[43]  P. McGorry,et al.  Does treatment delay in first-episode psychosis really matter? , 2000, Schizophrenia Research.

[44]  R. Drake,et al.  The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. , 2000, Schizophrenia bulletin.

[45]  E. Kuipers,et al.  Family intervention in psychosis: who needs it? , 1999, Epidemiologia e Psichiatria Sociale.

[46]  E. Johnstone,et al.  Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS) , 1999, Psychological Medicine.

[47]  Jane S. Paulsen,et al.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients. , 1999, Archives of general psychiatry.

[48]  K. Nuechterlein,et al.  Neurobehavioral deficits at adolescence in children at risk for schizophrenia: The Jerusalem Infant Development Study. , 1999, Archives of general psychiatry.

[49]  N. Tarrier,et al.  Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia , 1999, British Journal of Psychiatry.

[50]  B. Everitt,et al.  The effects of neurocognitive remediation on executive processing in patients with schizophrenia. , 1999, Schizophrenia bulletin.

[51]  N. Tarrier,et al.  Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia , 1998, BMJ.

[52]  R. Rosenheck,et al.  Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1998, Archives of general psychiatry.

[53]  J. Hooley,et al.  Expressed emotion and psychiatric relapse: a meta-analysis. , 1998, Archives of general psychiatry.

[54]  S. Kapur,et al.  Pharmacotherapy of first-episode schizophrenia , 1998, British Journal of Psychiatry.

[55]  G. Kirov,et al.  Randomised controlled trial of compliance therapy , 1998, British Journal of Psychiatry.

[56]  T. Robbins,et al.  Executive function in first-episode schizophrenia , 1998, Psychological Medicine.

[57]  B. Rund,et al.  A review of longitudinal studies of cognitive functions in schizophrenia patients. , 1998, Schizophrenia bulletin.

[58]  Susan Cooley,et al.  Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates , 1997 .

[59]  J. Waddington,et al.  Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia , 1997, Psychological Medicine.

[60]  G. Hogarty,et al.  Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. , 1997, The American journal of psychiatry.

[61]  G. Dunn,et al.  London–East Anglia randomised controlled trial of cognitive–behavioural therapy for psychosis , 1997, British Journal of Psychiatry.

[62]  G. Hogarty,et al.  Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. , 1997, The American journal of psychiatry.

[63]  M. Goldstein Psycho-education and family treatment related to the phase of a psychotic disorder , 1996, International clinical psychopharmacology.

[64]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[65]  P. Hayward,et al.  Compliance therapy in psychotic patients: randomised controlled trial , 1996, BMJ.

[66]  R. Dushay,et al.  Multiple-family groups and psychoeducation in the treatment of schizophrenia. , 1994, Archives of general psychiatry.

[67]  P. Dingemans,et al.  Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.

[68]  J. Lieberman,et al.  Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. , 1992, Schizophrenia bulletin.

[69]  H. Berenbaum,et al.  Psychodynamic treatment of schizophrenia: is there a future? , 1990, Psychological Medicine.

[70]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[71]  J. Leff,et al.  The Influence of Family and Social Factors on the Course of Psychiatric Illness , 1976, British Journal of Psychiatry.